speakere-Presentations

This e-presentation explains the regulatory specificities of biosimilars in the context of competition law and gives an overview of the expected strategies of the pharmaceutical industry to restrict competition of biosimilars on the market.

e-Presentation | March 2020 | Learning time: 34 minutes

Nicolas Pourbaix

Watch the premium version       Purchase the premium version    


speakere-Presentations

After giving a critical appraisal of the consequences of recent judgments adopted by the CJEU on access to documents held by EMA, this e-presentation presents some of the industry challenges raised by the implementation of the new in-vitro diagnostic regulation, as well as by Brexit.

e-Presentation | March 2020 | Learning time: 42 minutes

Elisabethann Wright

Watch the premium version       Purchase the premium version